Skip to main content
Premium Trial:

Request an Annual Quote

LSBC Completes $8.2M Placement

NEW YORK, March 10 (GenomeWeb News) - Large Scale Biology today announced the completion of an $8.2 million private placement. The company sold 5.2 million new shares of common stock, and issued warrants with a five-year-term to purchase an additional 1.3 million shares.

 

Proceeds from the private placement will be used to fund product development; meet expected strategic partnership commitments; and facilitate short-term revenue streams, the company said.

 

Large Scale Biology in February reported a 38 percent drop in its fourth-quarter revenues, year over year, along with a drop in R&D spending and narrowed losses. The company had revenues of $621,000 for the quarter ended Dec. 31, 2003, down from $997,000 in the year-ago period.  LSBC's net loss for the period was $7.1 million, down from $7.3 million for the fourth quarter of 2002. As of Dec. 31, 2003, the company had $7.7 million in cash and marketable securities.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.